Chris Zeal  새 기사를 만들었습니다
9 안에

JARDIANCE for CKD: A Turning Point in Nephrology? | # healthcare #empagliflozin #jardiance #chronic Kidney Disease

JARDIANCE for CKD: A Turning Point in Nephrology?

JARDIANCE for CKD: A Turning Point in Nephrology?

JARDIANCE (empagliflozin), a sodium-glucose co-transporter-2 (SGLT2) inhibitor, has shown significant promise in improving outcomes for CKD patients.